BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bartesaghi R, Vicari S, Mobley WC. Prenatal and Postnatal Pharmacotherapy in Down Syndrome: The Search to Prevent or Ameliorate Neurodevelopmental and Neurodegenerative Disorders. Annu Rev Pharmacol Toxicol 2022;62:211-33. [PMID: 34990205 DOI: 10.1146/annurev-pharmtox-041521-103641] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen X, Zuo X, Becker A, Head E, Mobley WC. Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene dose. Alzheimer's & Dementia 2022. [DOI: 10.1002/alz.12835] [Reference Citation Analysis]
2 Martínez-cué C, Bartesaghi R. Fatty Acids: A Safe Tool for Improving Neurodevelopmental Alterations in Down Syndrome? Nutrients 2022;14:2880. [DOI: 10.3390/nu14142880] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Morsiani C, Bacalini MG, Collura S, Moreno-Villanueva M, Breusing N, Bürkle A, Grune T, Franceschi C, De Eguileor M, Capri M. Blood circulating miR-28-5p and let-7d-5p associate with premature ageing in Down Syndrome. Mech Ageing Dev 2022;:111691. [PMID: 35780970 DOI: 10.1016/j.mad.2022.111691] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]